Pharma has so far been exempted from Trump's tariff blitz, which imposed a flat rate of 10% on imports from 5th April and ...

Rival companies trying to develop oral weight-loss candidates include Novo Nordisk, which has an oral formulation of ...

Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell ...

The Advisory Committee on Immunisation Practices (ACIP) has voted to widen the recommendations on the use of RSV shots to ...

The South San Francisco biotech has acquired rights to tralesinidase alfa, an enzyme replacement therapy (ERT) for the ...

Greater availability of real-world data and real-world evidence is rapidly changing the landscape of drug development.

A complaint against GSK accusing it of a major breach of the pharma industry's code of practice on prescribing information has been upheld after a review by the Prescription Medicines Code of Practice ...

Access to UK Biobank data by researchers based in China has sparked headlines in the UK about potential security concerns, ...

The policy was the buzz of the International Society for Health Economics and Outcomes Research (ISPOR) annual European ...

In one move that will please the drug industry, Trump has promised to do away with the detested 'pill penalty', a shorter ...

Johnson & Johnson has said it expects to see a $400 million financial hit from President Trump's tariffs, which will be felt ...

The EU approval comes after Eisai and Biogen were given approval for a new once-monthly intravenous maintenance dose of ...